New indolocarbazole and tetrazine derivatives
Russ. Chem. Bull., Int. Ed., Vol. 70, No. 6, June, 2021
1115
2θ scan range of 3—15 deg). Thin layers of compounds 5 and 6a
were prepared by spin coating from solutions in chloroform
(С = 10 mg L–1; centrifugation at 1000 rev min–1 for 1 min).
The carrier mobility was determined by the MIS—CELIV
method using sandwich-type samples prepared as follows. A glassy
substrate was coated with an ITO (mixture of In2O3 and SnO2)
conductive layer and then with a 70-nm SiO2 layer. Then, it was
successively coated with a layer of the compound under study
(layer thickness d = 100 nm) and with an Al layer (d = 80 nm)
as a counterelectrode. The SiO2 insulating layer played the role
of the blocking layer for both types of charge carriers, i.e., it
precluded injection of the charge carriers from ITO. When mea-
suring the transient hole current, a positive potential linearly
increasing at a rate of А = 5•104 V s–1 was applied to ITO; this
was accompanied by the extraction of holes at the Al electrode.
To measure the electron mobility, the polarity of the potential
applied to the electrode was reversed. The characteristic time
(tmax) corresponding to the maximum transient conduction
current was determined using the current signal detected at the
load resistor of a DL-Analog Discovery (Digilent Co.) oscillo-
scope. The carrier mobility was calculated using the expression
μ = 2d2/(At2max).18
С, 78.63; H, 7.12; N, 8.63. C42H44F2N4. Calculated (%):
С, 78.47; H, 6.90; N, 8.72. 1H NMR (C6D6, δ): 0.78—0.85
(m, 10 Н, 2 CH2CH3); 0.94—1.00 (m, 4 Н, 2 CH2); 1.08—1.15
(m, 4 H, 2 CH2); 1.35—1.41 (m, 4 H, 2 CH2); 2.74 (br.s, 4 Н,
2 NH2); 3.61—3.64 (m, 4 H, 2 NCH2); 6.16 (d, 2 H, C(1)H,
C(7)H, J = 2.2 Hz); 6.65 (dd, 2 H, C(3)H, C(9)H, J1 = 8.5 Hz,
J2 = 2.2 Hz); 6.94—6.98, 7.38—7.41 (both m, 4 Н each, 8 CHAr);
7.06 (d, 2 H, C(4)H, C(10)H, J = 8.5 Hz). 13С NMR (C6D6, δ):
14.17, 22.86, 26.73, 28.86, 31.75, 44.83, 108.91 (d, J = 98.4 Hz);
115.68 (d, 2 С, J = 23.9 Hz); 115.94, 117.36, 123.14, 124.51,
132.78 (d, 2 С, J = 7.7 Hz); 133.76, 135.80, 137.79, 139.34,
162.07, 164.03.
5,11-Dihexyl-6,12-bis(4-hexyloxyphenyl)-5,11-dihydroind-
olo[3,2-b]carbazole-2,8-diamine (4b). The yield was 597 mg
(74%). M.p. 174—175 °С. Rf = 0.75 (with THF as eluent).
Found (%): С, 80.11; H, 8.92; N, 6.76. C54H70N4O2. Calculat-
ed (%): С, 80.35; H, 8.74; N, 6.94. 1H NMR (C6D6, δ): 0.84
(t, 6 Н, 2 CH3, J = 7.3 Hz); 0.88—0.93 (m, 10 Н, 2 CH2, 2 CH3);
0.99—1.05 (m, 4 Н, 2 CH2); 1.12—1.19 (m, 4 H, 2 CH2);
1.22—1.31 (m, 8 H, 4 CH2); 1.36—1.42 (m, 4 H, 2 CH2);
1.46—1.54 (m, 4 H, 2 CH2); 1.67—1.72 (m, 4 H, 2 CH2); 2.76
(br.s, 4 Н, 2 NH2); 3.78—3.81 (m, 8 H, 2 NCH2, 2 OCH2); 6.49
(d, 2 H, C(1)H, C(7)H, J = 2.2 Hz); 6.66 (dd, 2 H, C(3)H, C(9)H,
Compounds 1, 2a,b14 and 3,6-bis(3,5-dimethylpyrazol-1-
yl)-1,2,4,5-tetrazine (DPTz)15 were synthesized following known
procedures. Commercially available reactants and solvents were
used without additional purification.
J1 = 8.4 Hz, J2 = 2.2 Hz); 7.03, 7.58 (both d, 4 Н each, 8 CHAr
J = 8.6 Hz); 7.10 (d, 2 H, C(4)H, C(10)H, J = 8.4 Hz).
,
Substitution of 3,5-dimethylpyrazolyl group in DPTz under
the action of amines 3 and 4a,b (general procedure). To a solution
of amine (0.5 mmol) in toluene (20 mL), DPTz (135 mg,
0.5 mmol in the case of amine 3 or 270 mg, 1 mmol in the case
of diamines 4a,b) was added. The reaction mixture was kept at
60 °С under stirring for 5 h and an additional 24 h at room tem-
perature. The precipitate was filtered off. Product 5 was washed
with CH3CN. Compounds 6a,b were recrystallized from DMF,
washed with acetonitrile, and dried at a pressure of 15 mbar and
at a temperature of 110 °С for 5 h.
Reduction of nitro derivatives 1 and 2a,b to amino derivatives
3 and 4a,b, respectively (general procedure). To a vigorously
stirred mixture of 2,8-dinitro derivative 2 (1 mmol) and zinc
powder (1.3 g, 20 mmol) in THF (40 mL), 12 М HCl (5.2 mL,
62.4 mmol) was added dropwise. The reaction mixture was re-
fluxed with stirring until complete dissolution of zinc. Then, 5%
NaOH (100 mL) was added and the product was extracted with
CH2Cl2 (3×20 mL). The solvent was evaporated at a reduced
pressure and a solid residue thus obtained was dissolved in THF
(3 mL), and ethanol (10 mL) was added. The precipitate (amino
derivative) was filtered off, washed with ethanol (2×2 mL), and
dried at 110 °C. Reduction of the mononitro derivative using this
procedure involved treatment of compound 1 (310 mg, 0.5 mmol)
with Zn powder (330 mg, 5 mmol) and 12 М HCl (1.3 mL,
15.6 mmol) in THF (10 mL).
5,11-Dihexyl-6,12-diphenyl-5,11-dihydroindolo[3,2-b]carb-
azol-2-amine (3). The yield was 243 mg (82%). M.p. 193—195 °С.
Rf = 0.71 (with THF as eluent). Found (%): С, 85.32; H, 7.58;
N, 6.98. C42H45N3. Calculated (%): С, 85.24; H, 7.66; N, 7.10.
1H NMR (C6D6, δ): 0.76—0.84 (m, 10 Н, 2 CH2CH3); 0.95—1.01
(m, 4 Н, 2 CH2); 1.09—1.17 (m, 4 H, 2 CH2); 1.40—1.47 (m, 4 H,
2 CH2); 2.75 (br.s, 2 Н, NH2); 3.69—3.72 (m, 4 H, 2 NCH2);
6.19 (d, 1 H, C(1)H, J = 2.2 Hz); 6.65 (dd, 1 H, C(3)H,
J1 = 8.5 Hz, J2 = 2.2 Hz); 6.98—7.00, 7.03—7.04 (both m,
1 Н each, С(8)Н, С(9)Н); 7.07 (d, 1 H, C(4)H, J = 8.5 Hz);
N-[6-(3,5-Dimethylpyrazol-1-yl)-1,2,4,5-tetrazine-3-yl]-
5,11-dihexyl-6,12-diphenyl-5,11-dihydroindolo[3,2-b]carbazol-
2-amine (5). The yield was 326 mg (85%). M.p. 211—213 °С.
Rf = 0.44 (with CH2Cl2 as eluent). Found (%): С, 76.85; H, 6.89;
N, 16.32. C49H51N9. Calculated (%): С, 76.83; H, 6.71; N, 16.46.
1H (DMSO-d6, δ): 0.80—0.90 (m, 10 Н, 2 CH2CH3); 1.04—1.12
(m, 4 Н, 2 CH2); 1.15—1.23 (m, 4 H, 2 CH2); 1.35—1.48 (m, 4 H,
2 CH2); 2.26, 2.48 (both s, 3 Н each, 2 CH3 in pyrazolyl);
3.74—3.82 (m, 4 H, 2 NCH2); 6.24 (s, 1 Н, С(4)Н in pyrazolyl);
6.36 (d, 1 H, C(10)H, J = 7.7 Hz); 6.76 (dd, 1 H, C(8)H,
J1 = 8.2 Hz, J2 = 7.0 Hz); 6.92 (d, 1 Н, C(1)H, J = 1.9 Hz); 7.30
(dd, 1 H, C(9)H, J1 = 7.7 Hz, J2 = 7.0 Hz); 7.41 (d, 1 H, C(7)H,
J = 8.2 Hz); 7.47 (d, 1 H, C(4)H, J = 8.8 Hz); 7.53 (dd, 1 H,
C(3)H, J1 = 8.8 Hz, J2 = 1.9 Hz); 7.59—7.72 (m, 10 Н, 2 Ph);
10.68 (br.s, 1 Н, NH). 13С NMR (DMSO-d6, δ): 12.33, 13.28,
13.73, 13.75, 21.91, 21.93, 25.60, 25.63, 28.14, 28.26, 30.71,
30.72, 43.65, 43.78, 108.63, 108.67, 108.72, 115.11, 117.71,
117.73, 117.90, 120.57, 121.60 (2 C), 122.02 (2 C), 122.13,
125.46, 128.21, 128.29, 128.33, 128.99 (2 C), 129.05 (2 C), 129.81
(2 C), 130.11 (2 C), 131.68, 132.11, 137.37, 137.97, 139.30,
141.40, 142.11, 150.16, 156.94, 160.41.
7.20 (d, 1 H, СНICZ, J = 8.2 Hz); 7.28—7.36 (m, 7 Н, 6 СНPh
,
1 CHICZ); 7.60—7.64 (m, 4 Н, 4 СНPh). 13С NMR (C6D6, δ):
14.20 (2 C), 22.88 (2 C), 26.65, 26.68, 28.86, 28.94, 31.72, 31.76,
44.66, 44.78, 108.72, 108.85, 109.20, 115.53, 118.47, 118.52,
123.05, 123.11, 123.34, 124.05, 124.63, 125.69, 127.89, 128.06,
128.31, 128.93 (2 C), 129.10 (2 C), 131.04 (2 C), 131.14 (2 C),
132.82, 133.91, 137.80, 139.20, 139.95, 139.97, 143.34.
N2,N8-Bis[6-(3,5-dimethylpyrazol-1-yl)-1,2,4,5-tetrazine-
3-yl]-6,12-bis(4-fluorophenyl)-5,11-dihexyl-5,11-dihydroindolo-
[3,2-b]carbazole-2,8-diamine (6a). The yield was 307 mg (62%).
M.p. 334—335 °С. Rf = 0.74 (with EtOAc—C6H14 (1 : 1) as
6,12-Bis(4-fluorophenyl)-5,11-dihexyl-5,11-dihydroindolo-
[3,2-b]carbazole-2,8-diamine (4a). The yield was 508 mg (79%).
M.p. 274—275 °С. Rf = 0.73 (with THF as eluent). Found (%):
eluent). Found (%): С, 67.78; H, 5.78; N, 22.61. C56H56F2N16
.